BioNote, Inc. (KRX:377740)
5,440.00
+70.00 (1.30%)
At close: Mar 13, 2026
12.75% (1Y)
| Market Cap | 551.41B +17.6% |
| Revenue (ttm) | 115.09B +15.3% |
| Net Income | 117.65B +191.5% |
| EPS | 1,160.97 +193.9% |
| Shares Out | 101.36M |
| PE Ratio | 4.69 |
| Forward PE | n/a |
| Dividend | 200.00 (3.68%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 142,138 |
| Average Volume | 175,707 |
| Open | 5,400.00 |
| Previous Close | 5,370.00 |
| Day's Range | 5,280.00 - 5,500.00 |
| 52-Week Range | 4,150.00 - 6,320.00 |
| Beta | 0.89 |
| RSI | 46.08 |
| Earnings Date | Feb 25, 2026 |